Ping An Biomedical Co., Ltd.

PROPOSAL FIVE

TO RESOLVE as an ordinary resolution to approve the Company’s share capital (whether issued or unissued) to be consolidated at the applicable ratio pursuant to the terms and conditions provided below (the “Further Share Consolidation”):

i. at any time after the conclusion of the Meeting, if the closing price of the Company’s class A ordinary shares falls below US$1.00 for twenty (20) consecutive trading days and is less than US$1.00 and equal to or above $0.50 at the closing of the market on the twentieth (20) trading day, the Company’s share capital (whether issued or unissued), shall be consolidated at a ratio of ten (10) to one (1), such that (i) every ten (10) class A ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class A ordinary share of a par value of US$0.025 each, and (ii) every ten (10) class B ordinary shares of a par value of US$0.0025 each be consolidated into one class B ordinary share of a par value of US$0.025 (the “10-1 Share Consolidation”), and the rounding up of any fractional shares resulting from the 10-1 Share Consolidation to the nearest whole ordinary share, which shall take effect on the twenty-first (21) trading day, and upon the 10-1 Share Consolidation becoming effective, the authorized share capital of the Company shall be changed:

TO: US$12,500,000 divided into 490,000,000 class A ordinary shares of a par value US$0.025 each and 10,000,000 class B ordinary shares of a par value US$0.025 each;

ii. at any time after the conclusion of the Meeting, if the closing price of the Company’s class A ordinary shares falls below US$1.00 for twenty (20) consecutive trading days and is less than US$0.50 and equal to or above US$0.25 at the closing of the market on the twentieth (20) trading day, the Company’s share capital (whether issued or unissued), shall be consolidated at a ratio of twenty (20) to one (1), such that (i) every 20 class A ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class A ordinary share of a par value of US$0.05 each, and (ii) every 20 class B ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class B ordinary share of a par value of US$0.05 (the “20-1 Share Consolidation”), and the rounding up of any fractional shares resulting from the 20-1 Share Consolidation to the nearest whole ordinary share, which shall take effect on the twenty-first (21) trading day, and upon the 20-1 Share Consolidation becoming effective, the authorized share capital of the Company shall be changed:

TO: US$12,500,000 divided into 245,000,000 class A ordinary shares of a par value US$0.05 each and 5,000,000 class B ordinary shares of a par value US$0.05 each;

iii. at any time after the conclusion of the Meeting, if the closing price of the Company’s class A ordinary shares falls below US$1.00 for twenty (20) consecutive trading days and is less than US$0.25 and equal to or above US$0.10 at the closing of the market on the twentieth (20) trading day, the Company’s share capital (whether issued or unissued), shall be consolidated at a ratio of fifty (50) to one (1), such that (i) every 50 class A ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class A ordinary share of a par value of US$0.125 each, and (ii) every 50 class B ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class B ordinary share of a par value of US$0.125 (the “50-1 Share Consolidation”), and the rounding

up of any fractional shares resulting from the 50-1 Share Consolidation to the nearest whole ordinary share, which shall take effect on the twenty-first (21) trading day, and upon the 50-1 Share Consolidation becoming effective, the authorized share capital of the Company shall be changed:

TO: US$12,500,000 divided into 98,000,000 class A ordinary shares of a par value US$0.125 each and 2,000,000 class B ordinary shares of a par value US$0.125 each;

iv. at any time after the conclusion of the Meeting, if the closing price of the Company’s class A ordinary shares falls below US$1.00 for five (5) consecutive trading days and is less than US$0.10 at the closing of the market on the sixth (6) trading day, the Company’s share capital (whether issued or unissued), shall be consolidated at a ratio of eighty (80) to one (1), such that (i) every 80 class A ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class A ordinary share of a par value of US$0.2 each, and (ii) every 80 class B ordinary shares of a par value of US$0.0025 each be consolidated into one (1) class B ordinary share of a par value of US$0.2 (the “80-1 Share Consolidation”), and the rounding up of any fractional shares resulting from the 80-1 Share Consolidation to the nearest whole ordinary share, which shall take effect on the sixth (6) trading day, and upon the 80-1 Share Consolidation becoming effective, the authorized share capital of the Company shall be changed:

TO: US$12,500,000 divided into 61,250,000 class A ordinary shares of a par value US$0.2 each and 1,250,000 class B ordinary shares of a par value US$0.2 each.